Prognostic Value of BRCA1 and BRCA2 Gene Mutations in Prostate Cancer: a Literature ReviewPrognostic Value of
BRCA1 and
BRCA2 Gene Mutations in Prostate Cancer: a Literature Review
New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patientsGervas, Polina A.,
Molokov, A.,
Ivanova, Anna,
Panferova, Yelena,
Kiselev, A. M,
Chernyshova, A.,
Pisareva, Lubov,
Choynzonov, Evgeny L.,
Cherdyntseva, Nadezhda V. in the
BRCA1 gene (rs80357868) and possibly damaging (PolyPhen
2)
germline variants in the ATM (rs781023264
LYNCH SYNDROME GERMLINE MUTATIONS IN BREAST CANCER: NEXT GENERATION SEQUENCING CASE-CONTROL STUDY OF 1,263 PARTICIPANTSNIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (BC). In this study, we performed Targeted Next-Generation Sequencing of MMR pathway
genes MLH
1, MSH
2 LYNCH SYNDROME GERMLINE MUTATIONS IN BREAST CANCER: NEXT GENERATION SEQUENCING CASE-CONTROL STUDY OF 1,263 PARTICIPANTSNIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (BC). In this study, we performed Targeted Next-Generation Sequencing of MMR pathway
genes MLH
1, MSH
2